Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/1999
08/10/1999US5935938 Substituted liposaccharides useful in the treatment and prevention of endotoxemia
08/10/1999US5935931 Human apoptosis-related calcium-binding protein
08/10/1999US5935865 Semaphorin gene family
08/10/1999US5935830 Site-directed mutagenesis by forming triple helix with double-stranded dna and oligonucleotide with electrophilic group, electrophilic group causes modification of dna nucleotide, then replication causes mutation
08/10/1999US5935816 Isolated polynucleotide and process for producing lysyl trna synthetase using host cells and vectors; use is to screen for antibacterial compounds
08/10/1999US5935814 G-protein coupled receptor family polypeptides, referred to as hfgan72y, altered nucleic acid seqences encoding it and recombinant materials and methods for its production; use in design of protocols and treatment of various infections
08/10/1999US5935776 Small molecule inhibition of RNA/ligand binding
08/10/1999US5935582 Hog cholera virus vaccine and diagnostic
08/10/1999US5935580 Recombinant adenylate cyclase of bordetella comprising at least one heterologous insert, such as an epitope at a permissive site within the n-terminal portion of the adneylate cyclase; and which exhibits invasive activity
08/10/1999US5935579 A peptide will stimulate proliferation of a t-cell clone in a t-cell proliferation assay and produce an alloepitopic effect, peptide when administered in a tolerizing amount will suppress proliferation of t-cell clone in second assay
08/10/1999US5935573 Hybrid protein
08/10/1999US5935568 Gene therapy for effector cell regulation
08/10/1999US5935565 Method for increasing the level of stem cells in peripheral blood
08/10/1999US5935564 Use of hydrophobic interaction chromatography to purify polyethylene glycols
08/10/1999CA2145078C Crystalline penicillin derivative, and its production and use
08/10/1999CA2126863C Chimeric immunogens
08/10/1999CA2070882C A process for large-scale production of antimicrobial peptide in high purity
08/10/1999CA1340704C Human interferon-gamma, process to prepare said human interferon-gamma, and its use
08/10/1999CA1340695C Antibacterial agents
08/09/1999WO1999039680A1 Antifungal nail lacquer and method using same
08/05/1999WO1999038969A1 PROTEIN HUMAINE β-TrCP
08/05/1999WO1999038888A2 Peptide inhibitors of the serine protease activity associated to the ns3 protein of hcv, relevant uses and process of production
08/05/1999WO1999038882A1 Human cystatin f
08/05/1999WO1999038880A1 Genetic immunization with nonstructural proteins of hepatitis c virus
08/05/1999WO1999038868A1 Azolo triazines and pyrimidines
08/05/1999WO1999038862A1 Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof
08/05/1999WO1999038843A1 Hydroxamic and carboxylic acid derivatives
08/05/1999WO1999038529A1 Vaccine composition comprising milled lyophilisate of antigenic whole cells
08/05/1999WO1999038524A2 Therapeutic administration of low density lipoprotein receptor for viral infections and immune regulation
08/05/1999WO1999038522A1 Herbal anti-viral agent
08/05/1999WO1999038521A1 The use of combinations of active agents consisting of antimicrobially active substances and plant extracts containing terpene in veterinary medicine
08/05/1999WO1999038514A1 Cyclic amine modulators of chemokine receptor activity
08/05/1999WO1999038508A1 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
08/05/1999WO1999038380A1 Improved extracorporeal methods for enhancing antigen presentation and immune responsiveness
08/05/1999WO1999028493A3 Method for identifying inhibitors of g-protein coupled receptor hibef51
08/05/1999WO1999024559A3 Nuclear targeting by means of streptococcal protein h
08/05/1999WO1999022763A3 Encapsulated immunomodulators useful as vaccine adjuvants
08/05/1999WO1999014226A3 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleotide analogues
08/05/1999WO1999009186A3 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
08/05/1999WO1995031429A8 Photocleavable agents and conjugates for the detection and isolation of biomolecules
08/05/1999DE19804301A1 Tincture for treating inflammatory skin and mucosal disorders, especially mouth ulcers
08/05/1999CA2319781A1 Cyclic amine modulators of chemokine receptor activity
08/05/1999CA2319465A1 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
08/05/1999CA2319411A1 Herbal anti-viral agent
08/05/1999CA2319306A1 Peptide inhibitors of the serine protease activity associated to the ns3 protein of hcv, relevant uses and process of production
08/05/1999CA2319081A1 Human cystatin f
08/05/1999CA2318833A1 The use of combinations of active agents consisting of antimicrobially active substances and plant extracts containing terpene in veterinary medicine
08/05/1999CA2318744A1 Genetic immunization with nonstructural proteins of hepatitis c virus
08/04/1999EP0933372A1 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
08/04/1999EP0933351A1 Tricyclic retinoids, methods for their production and use
08/04/1999EP0933350A1 Tricyclic retinoids, methods for their production and use
08/04/1999EP0932683A1 Attenuated microorganism strains expressing hpv proteins
08/04/1999EP0932681A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/04/1999EP0932680A2 Compositions and methods for the prevention and diagnosis of human granulocytic ehrlichiosis
08/04/1999EP0932665A1 Method for sorting antifungal molecules acting on the glucanosyltransferase activity
08/04/1999EP0932661A1 Livestock mucosal competitive exclusion culture to reduce enteropathogenic bacteria
08/04/1999EP0932623A1 Colostrinin, and uses thereof
08/04/1999EP0932613A1 BLOCKING EXPRESSION OF VIRULENCE FACTORS IN $i(S. AUREUS)
08/04/1999EP0932600A2 SULFONAMIDE SUBSTITUTED ASPARTIC ACID INTERLEUKIN-1$g(b) CONVERTING ENZYME INHIBITORS
08/04/1999EP0932598A1 ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
08/04/1999EP0932420A1 Drug delivery using terminal complement components
08/04/1999EP0932413A1 Method for treatment of immunodeficiency virus infection
08/04/1999EP0932412A1 Antiviral treatment
08/04/1999EP0932408A1 Pharmaceutical and cosmetic formulations with antimicrobial activity
08/04/1999EP0748311B1 Therapeutic benzonitriles
08/04/1999EP0740653B1 Hydroxamic acid derivatives as metalloproteinase inhibitors
08/04/1999EP0590026B1 Orally active antiviral compounds
08/04/1999EP0538437B1 Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
08/04/1999CN1225096A Bromotiacumicin compounds
08/04/1999CN1225085A Substituted pyridines as selective cyclooxygenase-2 inhibitors
08/04/1999CN1225011A Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as the active ingredient
08/04/1999CN1224718A Thiazole derivatives
08/04/1999CN1224621A Rotavirus resisting immune globulin composite and its preparation and use
08/04/1999CN1044478C Quillaja saponin adjuvant and vaccine formulation containing same
08/03/1999US5932726 Asymmetric synthesis of benzoxazinones
08/03/1999US5932717 Methods of obtaining DNA-RNA hybrids from sturgeon milt
08/03/1999US5932710 Alkylation, oximination, deblocking
08/03/1999US5932701 ribA
08/03/1999US5932614 Sulfonic stilbene compounds in the treatment of viral diseases
08/03/1999US5932609 Pharmaceutical composition for inhibiting the growth of cancers
08/03/1999US5932604 Pharmaceutical compositions for the treatment of viral infections
08/03/1999US5932598 Prodrugs of benzenesulfonamide-containing COX-2 inhibitors
08/03/1999US5932554 Prevent binding of toxins to receptors
08/03/1999US5932536 Compositions for neutralization of lipopolysaccharides
08/03/1999US5932476 Cloning of chicken anemia virus DNA
08/03/1999US5932469 Antimicrobial polypeptide, nucleic acid, and methods of use
08/03/1999US5932425 Compositions and methods for modulating cellular NF-κB activation
08/03/1999US5932236 Pharmaceutical composition and methods for using it
08/03/1999US5932224 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
08/03/1999US5932223 Rotavirus vaccine formulations
08/03/1999US5932222 Mutant respiratory syncytial virus (RSV), vaccines containing same and methods of use
08/03/1999US5932219 Polypeptides
08/03/1999US5932218 Multideterminant peptides eliciting helper T-lymphocyte, cytotoxic T-lymphocyte, and neutralizing antibody responses against HIV-1
08/03/1999US5932208 Compositions and methods for the use of such compositions in human therapeutics, characterized by the association of a muramyl peptide with a cytokine
08/03/1999CA2184734C 3''-desmethoxy derivatives of erythromycin and azithromycin
08/03/1999CA2005815C Antiviral acyclic nucleoside derivatives
08/03/1999CA2003213C Antimycotically active cyclopropyl-substituted azolylmethylcarbinols
07/1999
07/30/1999CA2246001A1 Novel compounds
07/29/1999WO1999037781A1 Mutants of il-16, processes for their production, and their use
07/29/1999WO1999037678A2 Antimicrobial peptides
1 ... 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 ... 1798